Analgesic efficacy of low-dose ketamine - Somatosensory-evoked responses in relation to subjective pain ratings

被引:75
作者
Kochs, E
Scharein, E
Mollenberg, O
Bromm, B
amEsch, JS
机构
[1] UNIV HAMBURG, HOSP EPPENDORF, DEPT PHYSIOL, HAMBURG, GERMANY
[2] UNIV HAMBURG, HOSP EPPENDORF, DEPT ANESTHESIOL, HAMBURG, GERMANY
关键词
anesthetics; intravenous; ketamine; pain evoked responses; measurement techniques; SSEP; electroencephalography;
D O I
10.1097/00000542-199608000-00012
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Low-dose ketamine has been shown to exert analgesic effects. Whether ketamine-induced pain relief may be quantitated by somatosensory evoked cerebral potentials has not been established. Methods: Thirty healthy volunteers were assigned randomly to one of three groups. Subjects of group 1 (n = 10, control) were given saline as placebo. In groups 2 (n = 10) and 3 (n = 10), intravenous ketamine (0.25 mg . kg(-1) and 0.50 mg . kg(-1), respectively) was administered. The following variables were recorded at baseline and for 50 min after drug administration: electroencephalographic (EEG) data, somatosensory-evoked late cortical responses (SEP) elicited by intracutaneous stimulation of the fingertip (2-3 fold pain threshold), heart rate, mean arterial blood pressure, and end-tidal PET(CO2) via a tightfitting mask. Electroencephalographic spectral power in selected frequency bands and frequency percentiles were calculated from the spontaneous EEG segment preceding each somatosensory stimulus. Somatosensory-evoked late cortical response parameters were calculated from the respective poststimulus EEG segments. After recording of each EEG response, subjects were asked to rate the individual pain sensation. Results: In group 1, all variables did not change over time. Ketamine administration resulted in dose-dependent decreases in alpha-activity and increases in theta power (group 2: 190% group 3: 440%). Electroencephalographic changes were not related to changes in pain perception. For the first 30 min after ketamine injection, a dose-dependent decrease of the long-latency N-150-P-250 somatosensory-evoked late cortical response component was observed (group 2: 15-20%; group 3: 25-30%). Subjective pain ratings were also different between groups, with a higher degree of pain relief in group 3 for the first 30 min. At the end of the observation period, pain relief and the N-150-P-250 amplitude were comparable in both ketamine groups. Conclusions: These data indicate that pain relief induced by low-dose ketamine is dose-dependent for the first 30 min after bolus injection. Changes in pain perception may be quantitated by somatosensory-evoked cortical responses. Also, EEG changes are not specific for changes in nociception, but the increase in theta power may reflect the hypnotic effect of low-dose ketamine.
引用
收藏
页码:304 / 314
页数:11
相关论文
共 38 条
[1]  
[Anonymous], THEORY APPL DIGITAL
[2]   THE EFFECT OF N-METHYL-D-ASPARTATE ANTAGONIST (KETAMINE) ON SINGLE AND REPEATED NOCICEPTIVE STIMULI - A PLACEBO-CONTROLLED EXPERIMENTAL HUMAN STUDY [J].
ARENDTNIELSEN, L ;
PETERSENFELIX, S ;
FISCHER, M ;
BAK, P ;
BJERRING, P ;
ZBINDEN, AM .
ANESTHESIA AND ANALGESIA, 1995, 81 (01) :63-68
[3]  
BROMM B, 1985, METHOD FIND EXP CLIN, V7, P161
[4]   PRINCIPAL COMPONENT ANALYSIS OF PAIN-RELATED CEREBRAL POTENTIALS TO MECHANICAL AND ELECTRICAL-STIMULATION IN MAN [J].
BROMM, B ;
SCHAREIN, E .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1982, 53 (01) :94-103
[5]  
BROMM B, 1984, METHOD FIND EXP CLIN, V6, P405
[6]   PRE-STIMULUS POST-STIMULUS RELATIONS IN EEG SPECTRA AND THEIR MODULATIONS BY AN OPIOID AND AN ANTIDEPRESSANT [J].
BROMM, B ;
MEIER, W ;
SCHAREIN, E .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1989, 73 (03) :188-197
[7]   IMIPRAMINE REDUCES EXPERIMENTAL PAIN [J].
BROMM, B ;
MEIER, W ;
SCHAREIN, E .
PAIN, 1986, 25 (02) :245-257
[8]   ANTAGONISM BETWEEN TILIDINE AND NALOXONE ON CEREBRAL POTENTIALS AND PAIN RATINGS IN MAN [J].
BROMM, B ;
MEIER, W ;
SCHAREIN, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 87 (04) :431-439
[9]  
BROMM B, 1991, ARZNEIMITTEL-FORSCH, V41-2, P1123
[10]   OPIATE PHARMACOLOGY AND INDIVIDUAL-DIFFERENCES .2. SOMATOSENSORY EVOKED-POTENTIALS [J].
BUCHSBAUM, MS ;
DAVIS, GC ;
COPPOLA, R ;
NABER, D .
PAIN, 1981, 10 (03) :367-377